Peer-reviewedCC BYFrontiers in oncology
Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents
- 1The Mina and Everard Goodman Faculty of Life-Sciences, Bar-Ilan University , ,
Related
- Mathematical Analysis of a Two-Strain Tuberculosis Model Incorporating Treatment Success, Acquired Drug Resistance, Reactivation, and Reinfection
- Recentring young people in AI for mental health support: breaking the evidence-design feedback loop
- Burden and risk factors of acquisition of multi-drug-resistant Gram-negative bacteria among intensive care patients at a tertiary care setting.
- Interactive Pathways and Therapeutic Innovations in Elderly Sarcopenia-Diabetes Comorbidity: Breaking the Negative Self-Reinforcing Loop Through Integrated Care
- Breaking the Cycle: Rewiring Negative Symptoms in Schizophrenia Through Physical Exercise
BibTeX
@article{slotkiitzchakov2026breaking,
title = {{Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents}},
author = {Orel Slotki-Itzchakov and Sally Shpungin and Uri Nir},
journal = {Frontiers in oncology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655716},
note = {CC BY},
}
RIS
TY - JOUR
TI - Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents
AU - Orel Slotki-Itzchakov
AU - Sally Shpungin
AU - Uri Nir
PY - 2026
DA - 2026/10/16
JO - Frontiers in oncology
UR - https://europepmc.org/article/PMC/PMC13655716
SN - 2234-943X
ER -